Analyze Catalogue Methodology Blog Pro Access

⚡ Interrogation des APIs scientifiques en cours…

The quality score for scientific publications. 100% free, 100% independent.

Navigation

Home
Analyze an article
Methodology
Blog
My account

Transparency

Our independence
Methodological transparency
Pro Access
Contact us
Legal notice
Privacy
ToU
ToS
Glossary

Developers

Public API
GitHub

Free score, forever.

E (12/100) — Non fiable | Murrough JW et al. | Publi-Score

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

Murrough JW et al.·Biological Psychiatry·Dec 2013·PMID 23982301

Authors' conclusion

Positive

Does not affect the score

Publi-Score

12/100

Not reliableUpdated 6 day(s) ago

Score coverage

Abstract onlyAI analysis from abstract (~85% of criteria)54% of criteria evaluated

Category breakdown

Total raw score21.5/100

Integrity coefficient

A. Authors' integrity

COI declaration

0.90

Funding independence

0.95

Coeff. authors = avg(0.90, 0.95) = 0.93

B. Editorial process

Peer review

0.90

Submission→accept. delay

0.90

Coeff. editorial = avg(0.90, 0.90) = 0.90

min(0.93, 0.90) = 0.90← lowest dominates

🚫

Alert signal : eoc → Coefficient forced to 0.3

Financement partiel par industrie pharmaceutique (Janssen/J&J pour esketamine). COI potentiel non entièrement déclaré.

Final coefficient : 0.30

Final score = 21.5 × 0.30 = 12/100

Save

📄 Export PDF

PubMed DOI

Twitter/X LinkedIn

Contribute

Actions

Analyze another article View the methodology

Information

PMID: 23982301

DOI

10.1016/j.biopsych.2012.08.020

Mode

🔬 Partial AI (abstract)

Grid

v1.0

Scored on

4/18/2026

Impact Factor

12.8

Quartile

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

Category breakdown

Integrity coefficient

A. Authors' integrity

B. Editorial process

Save

Share

Contribute

Actions

Information